BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35456893)

  • 1. Resveratrol Prevents Cytoarchitectural and Interneuronal Alterations in the Valproic Acid Rat Model of Autism.
    Santos-Terra J; Deckmann I; Carello-Collar G; Nunes GD; Bauer-Negrini G; Schwingel GB; Fontes-Dutra M; Riesgo R; Gottfried C
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents long-term structural hippocampal alterations and modulates interneuron organization in an animal model of ASD.
    Santos-Terra J; Deckmann I; Schwingel GB; Paz AVC; Gama CS; Bambini-Junior V; Fontes-Dutra M; Gottfried C
    Brain Res; 2021 Oct; 1768():147593. PubMed ID: 34331907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism.
    Codagnone MG; Podestá MF; Uccelli NA; Reinés A
    Dev Neurosci; 2015; 37(3):215-31. PubMed ID: 25895486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the Hippocampal Networks in Valproic Acid-Induced Rat Autism Model.
    Bódi V; Májer T; Kelemen V; Világi I; Szűcs A; Varró P
    Front Neural Circuits; 2022; 16():772792. PubMed ID: 35185478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAergic synaptic transmission and cortical oscillation patterns in the primary somatosensory area of a valproic acid rat model of autism spectrum disorder.
    Fontes-Dutra M; Righes Marafiga J; Santos-Terra J; Deckmann I; Brum Schwingel G; Rabelo B; Kazmierzak de Moraes R; Rockenbach M; Vendramin Pasquetti M; Gottfried C; Calcagnotto ME
    Eur J Neurosci; 2023 Feb; 57(3):527-546. PubMed ID: 36504470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol prevents social deficits in animal model of autism induced by valproic acid.
    Bambini-Junior V; Zanatta G; Della Flora Nunes G; Mueller de Melo G; Michels M; Fontes-Dutra M; Nogueira Freire V; Riesgo R; Gottfried C
    Neurosci Lett; 2014 Nov; 583():176-81. PubMed ID: 25263788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol Prevents Cellular and Behavioral Sensory Alterations in the Animal Model of Autism Induced by Valproic Acid.
    Fontes-Dutra M; Santos-Terra J; Deckmann I; Brum Schwingel G; Della-Flora Nunes G; Hirsch MM; Bauer-Negrini G; Riesgo RS; Bambini-Júnior V; Hedin-Pereira C; Gottfried C
    Front Synaptic Neurosci; 2018; 10():9. PubMed ID: 29872390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
    Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
    Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
    Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
    Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure.
    Khodaverdi M; Rahdar M; Davoudi S; Hajisoltani R; Tavassoli Z; Ghasemi Z; Amini AE; Hosseinmardi N; Behzadi G; Janahmadi M
    Neurobiol Learn Mem; 2021 Sep; 183():107462. PubMed ID: 34015444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agmatine ameliorates valproic acid-induced depletion of parvalbumin-positive neuron.
    Khoram-Abadi KM; Basiri M; Nemati M; Nozari M
    Int J Dev Neurosci; 2024 Apr; 84(2):134-142. PubMed ID: 38304999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
    Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA.
    Hirsch MM; Deckmann I; Fontes-Dutra M; Bauer-Negrini G; Della-Flora Nunes G; Nunes W; Rabelo B; Riesgo R; Margis R; Bambini-Junior V; Gottfried C
    Food Chem Toxicol; 2018 May; 115():336-343. PubMed ID: 29510222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal baicalin ameliorates behavioral and neurochemical alterations in valproic acid-induced rodent model of autism: The possible implication of sirtuin-1/mitofusin-2/ Bcl-2 pathway.
    Elesawy RO; El-Deeb OS; Eltokhy AK; Arakeep HM; Ali DA; Elkholy SS; Kabel AM
    Biomed Pharmacother; 2022 Jun; 150():112960. PubMed ID: 35447549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorating age-dependent effects of resveratrol on VPA-induced social impairments and anxiety-like behaviors in a rat model of neurodevelopmental disorder.
    Shahrbabaki SSV; Moslemizadeh A; Amiresmaili S; Tezerji SS; Juybari KB; Sepehri G; Shamsi Meymandi M; Bashiri H
    Neurotoxicology; 2023 May; 96():154-165. PubMed ID: 36933665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex dependent alterations of resveratrol on social behaviors and nociceptive reactivity in VPA-induced autistic-like model in rats.
    Juybari KB; Sepehri G; Meymandi MS; Vakili Shahrbabaki SS; Moslemizadeh A; Saeedi N; Aminzadeh A; Nozari M; Khaksari M; Haghpanah T; Bashiri H
    Neurotoxicol Teratol; 2020; 81():106905. PubMed ID: 32534151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled estrogen receptor (GPER) selective agonist G1 attenuates the neurobehavioral, molecular and biochemical alterations induced in a valproic acid rat model of autism.
    Hameed RA; Ahmed EK; Mahmoud AA; Atef AA
    Life Sci; 2023 Sep; 328():121860. PubMed ID: 37331505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal spatiotemporal expression pattern of progranulin and neurodevelopment impairment in VPA-induced ASD rat model.
    Lan J; Hu Y; Wang X; Zheng W; Liao A; Wang S; Li Y; Wang Y; Yang F; Chen D
    Neuropharmacology; 2021 Sep; 196():108689. PubMed ID: 34175324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism.
    Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Ur Rehman N; Maneshian M
    Psychopharmacology (Berl); 2022 Aug; 239(8):2673-2693. PubMed ID: 35538250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.